Survey of Japanese nephrologists' use of clinical practice guidelines for rapidly progressive glomerulonephritis-Reference-Cited by-同舟云学术

Survey of Japanese nephrologists' use of clinical practice guidelines for rapidly progressive glomerulonephritis

Published:2023-12-28 Issue: Volume: Page:
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Takahashi-Kobayashi Mayumi,Sada Ken-Ei,Kawashima Soko,Miyawaki Yoshia,Nakazawa Daigo,Furuichi Kengo,Okada Hirokazu,Narita Ichiei,Usui Joichi^ORCID

Funder

Grant-in-Aid for Intractable Renal Diseases Research, Research on rare and intractable diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan.

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10157-023-02441-y.pdf

Reference4 articles.

1. Arimura Y, Muso E, Fujimoto S, et al. Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014. Clin Exp Nephrol. 2016;20(3):322–41. https://doi.org/10.1007/s10157-015-1218-8.

2. Takahashi-Kobayashi M, Usui J, Kaneko S, et al. Age-dependent survival in rapidly progressive glomerulonephritis: a nationwide questionnaire survey from children to the elderly. PLoS ONE. 2020;15(7):e0236017. https://doi.org/10.1371/journal.pone.0236017.

3. Chung SA, Langford CA, Maz M, et al. American College of rheumatology/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2021;73(8):1366–83. https://doi.org/10.1002/art.41773.

4. Usui J, Kawashima S, Sada KE, et al. A digest of the evidence-based clinical practice guideline for rapidly progressive glomerulonephritis 2020. Clin Exp Nephrol. 2021;25(12):1286–91. https://doi.org/10.1007/s10157-021-02096-7.